Plasmodium falciparum heme polymerization machinery (HPM)

The Plasmodium falciparum heme polymerization machinery is a critical survival mechanism used by the malaria parasite during its intraerythrocytic stage. As the parasite digests host hemoglobin within its acidic food vacuole to obtain amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes. To neutralize this threat, the parasite utilizes a specialized machinery—comprising the Heme Detoxification Protein (HDP), Histidine-Rich Proteins (HRP II and III), and neutral lipids—to polymerize free heme into an insoluble, non-toxic crystalline pigment called hemozoin. This pathway is the primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines like chloroquine. These drugs interfere with the crystallization process, causing toxic heme to accumulate and ultimately leading to the oxidative destruction of the parasite. Understanding this machinery is vital for overcoming widespread drug resistance, which often involves mutations in transporters that regulate drug access to this metabolic site.

Other names

Heme detoxification pathwayHemozoin formation machineryHeme biocrystallization pathwayHeme detoxification protein (HDP)Histidine-rich protein II (HRP II)

Inhibition of the biocrystallization of toxic free heme into non-toxic hemozoin, leading to the accumulation of ferriprotoporphyrin IX which causes oxidative damage and parasite death.